Riverhead Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $312K | Hold |
5,024
| – | – | 0.01% | 927 |
|
|
2019
Q2 | $358K | Buy |
5,024
+481
| +11% | +$34.3K | 0.01% | 881 |
|
|
2019
Q1 | $356K | Hold |
4,543
| – | – | 0.01% | 862 |
|
|
2018
Q4 | $385K | Hold |
4,543
| – | – | 0.02% | 756 |
|
|
2018
Q3 | $778K | Hold |
4,543
| – | – | 0.03% | 570 |
|
|
2018
Q2 | $587K | Hold |
4,543
| – | – | 0.02% | 627 |
|
|
2018
Q1 | $468K | Hold |
4,543
| – | – | 0.02% | 686 |
|
|
2017
Q4 | $388K | Buy |
4,543
+962
| +27% | +$82.2K | 0.02% | 766 |
|
|
2017
Q3 | $304K | Buy |
3,581
+699
| +24% | +$59.3K | 0.01% | 798 |
|
|
2017
Q2 | $218K | Buy |
2,882
+1,439
| +100% | +$109K | 0.01% | 880 |
|
|
2017
Q1 | $95K | Buy |
1,443
+161
| +13% | +$10.6K | 0.01% | 1026 |
|
|
2016
Q4 | $81K | Hold |
1,282
| – | – | 0.01% | 1057 |
|
|
2016
Q3 | $82K | Sell |
1,282
-23,263
| -95% | -$1.49M | 0.01% | 993 |
|
|
2016
Q2 | $608K | Buy |
24,545
+19,467
| +383% | +$482K | 0.02% | 560 |
|
|
2016
Q1 | $340K | Sell |
5,078
-693
| -12% | -$46.4K | ﹤0.01% | 1061 |
|
|
2015
Q4 | $390K | Buy |
5,771
+4,008
| +227% | +$271K | 0.01% | 1019 |
|
|
2015
Q3 | $94K | Buy |
+1,763
| New | +$94K | ﹤0.01% | 1126 |
|